miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells
暂无分享,去创建一个
Feng Shen | F. Shen | Guoxing Xu | Jin Wang | Yifan Kang | Guoxing Xu | Jin Wang | Yifan Kang
[1] E. Kleinerman,et al. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. , 2012, Cancer research.
[2] R. Gregory,et al. Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.
[3] E. Chan,et al. MicroRNA in TLR signaling and endotoxin tolerance , 2011, Cellular and Molecular Immunology.
[4] Kang Han,et al. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. , 2012, Oncology reports.
[5] Yusuke Yamamoto,et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Zhenfeng Duan,et al. MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.
[7] G. Hannon,et al. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3). , 1995, Cytogenetics and cell genetics.
[8] Xian-gui Hu,et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. , 2011, Carcinogenesis.
[9] Jintang Xia,et al. miR‐124 inhibits cell proliferation in gastric cancer through down‐regulation of SPHK1 , 2012, The Journal of pathology.
[10] H. Yokozaki,et al. Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.
[11] Shuai Li,et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. , 2013, Pathology, research and practice.
[12] Michael G. Garelick,et al. Neuronal activity rapidly induces transcription of the CREB‐regulated microRNA‐132, in vivo , 2009, Hippocampus.
[13] A. Davis,et al. Prognostic factors in osteosarcoma: a critical review. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Blay,et al. Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide response , 2011, International journal of cancer.
[15] G. Ottaviani,et al. The epidemiology of osteosarcoma. , 2009, Cancer treatment and research.
[16] V. Ambros. microRNAs Tiny Regulators with Great Potential , 2001, Cell.
[17] Yandan Yao,et al. MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.
[18] Jie Tang,et al. Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma , 2013, Molecular and Cellular Biochemistry.
[19] Jae Kwan Lee,et al. Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient , 2013, International Journal of Gynecologic Cancer.
[20] A. Levine,et al. DNA methylation silences miR-132 in prostate cancer , 2013, Oncogene.
[21] S. Alahari,et al. miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.
[22] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[23] Zhu Jianwei,et al. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell , 2013, Tumor Biology.
[24] David M. Thomas,et al. Cyclin E1 is amplified and overexpressed in osteosarcoma. , 2011, The Journal of molecular diagnostics : JMD.